Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Caño Ivan Collado
Introduction
Caño Ivan Collado is a notable inventor based in Alcobendas, Spain. He has made significant contributions to the field of medical science, particularly in the development of treatments for various health conditions. His work focuses on melanocortin receptor agonists, which have potential applications in treating obesity, diabetes, and sexual dysfunction.
Latest Patents
Collado holds a patent for melanocortin receptor agonists, specifically a compound described by the formula (I). This invention is particularly valuable as it offers a new approach to managing obesity and diabetes, as well as addressing male and female sexual dysfunction. The patent highlights the innovative nature of his work and its potential impact on healthcare.
Career Highlights
Collado is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His dedication to innovation in medicine is evident through his patent and ongoing projects.
Collaborations
Throughout his career, Collado has worked alongside talented colleagues, including Ryan Thomas Backer and Oscar De Frutos-Garcia. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of medical science.
Conclusion
Caño Ivan Collado's contributions to the field of medicine through his innovative patent on melanocortin receptor agonists demonstrate his commitment to improving health outcomes. His work at Eli Lilly and Company, along with his collaborations, positions him as a key figure in the ongoing quest for effective treatments for complex health issues.